|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.59 NGN | 0.00% |
|
-0.62% | -18.04% |
Neimeth International Pharmaceuticals Plc reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported sales was NGN 946.3 million. Net loss was NGN 180.31 million.
Basic loss per share from continuing operations was NGN 0.09.
| 1st Jan change | Capi. | |
|---|---|---|
| -18.04% | 4.58M | |
| +51.86% | 797B | |
| +40.51% | 628B | |
| -6.68% | 351B | |
| +17.08% | 323B | |
| +10.46% | 300B | |
| +16.87% | 244B | |
| +1.02% | 223B | |
| +5.68% | 163B | |
| -5.49% | 153B |
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC 
